India's Pharmaceutical Exports

Country Profile

Eswatini

Eswatini is an emerging destination for Indian pharmaceutical exports — $9.06M in FY 2025–26. Medicine Ingredients accounts for 56% of shipments, with vaccines contributing $392K.

🇸🇿 $9.06M · 0.5× growth since FY2015
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$9.06M
Exports FY2025–26 DGCIS
0.5×
Growth FY2015→2026
56%
Medicine Ingredients Share
4
Product Categories Supplied
12
Years of Trade Data
Eswatini is an emerging destination for Indian pharmaceutical exports — $9.06M in FY 2025–26. Medicine Ingredients accounts for 56% of shipments, with vaccines contributing $392K.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicine Ingredients $5.09M (56.1%) Medicines $3.13M (34.6%) Surgical & Hospital Supplies $448K (4.9%) Vaccines $392K (4.3%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Eswatini in the RBI overseas direct investment dataset (2011–2026).